Literature DB >> 15518810

Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10.

Guido van Marle1, Scot Henry, Tiona Todoruk, Andrea Sullivan, Claudia Silva, Sean B Rourke, Janet Holden, Justin C McArthur, M John Gill, Christopher Power.   

Abstract

HIV-1 Nef is expressed in astrocytes, but a contribution to neuropathogenesis and the development of HIV-associated dementia (HAD) remains uncertain. To determine the neuropathogenic actions of the HIV-1 Nef protein, the brain-derived (YU-2) and blood-derived (NL4-3) Nef proteins were expressed in neural cells using an alphavirus vector, which resulted in astrocyte death (P < 0.001). Supernatants from Nef-expressing astrocytes also caused neuronal death, suggesting the release of neurotoxic molecules by astrocytes. Analysis of pro-inflammatory gene induction in astrocytes expressing Nef revealed increased IP-10 mRNA expression (4000-fold) that was Nef sequence dependent. Recombinant IP-10 caused selective cell death in neurons (P < 0.001) but not astrocytes, and the cytotoxicity of supernatant from astrocytes expressing Nef YU-2 was blocked by an antibody directed against the chemokine receptor CXCR3 (P < 0.001). SCID/NOD mice implanted with a Nef YU-2-expressing vector displayed abnormal motor behavior (P < 0.05), neuroinflammation, and neuronal loss relative to controls. Analysis of mRNA levels in brains from patients with HAD also revealed increased expression of IP-10 (P < 0.05), which was confirmed by immunoreactivity detected principally in astrocytes. Phylogenetic and protein structure analyses of Nef sequences derived from HIV/AIDS patients with and without HAD suggested viral evolution toward a neurotropic Nef protein. These results indicate that HIV-1 Nef contributes to neuropathogenesis by directly causing astrocyte death together with indirect neuronal death through the cytotoxic actions of IP-10 on neurons. Furthermore, Nef molecular diversity was evident in brain tissue among patients with neurological disease and which may influence IP-10 production by astrocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518810     DOI: 10.1016/j.virol.2004.08.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  92 in total

1.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

Review 2.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 3.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 4.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

6.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

7.  West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

Authors:  Guido van Marle; Joseph Antony; Heather Ostermann; Christopher Dunham; Tracey Hunt; William Halliday; Ferdinand Maingat; Matt D Urbanowski; Tom Hobman; James Peeling; Christopher Power
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 8.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

9.  Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-kappaB in hippocampal neuronal cell culture.

Authors:  Hilda Bajova; Thomas E Nelson; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2008-03-10       Impact factor: 3.478

10.  Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.

Authors:  Navneet Dhillon; Xuhui Zhu; Fuwang Peng; Honghong Yao; Rachel Williams; Jianming Qiu; Shannon Callen; Amy O'Brien Ladner; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.